WO2001025469A3 - Procede de preparation de steroides modifies par fermentation de levures - Google Patents

Procede de preparation de steroides modifies par fermentation de levures Download PDF

Info

Publication number
WO2001025469A3
WO2001025469A3 PCT/FR2000/002753 FR0002753W WO0125469A3 WO 2001025469 A3 WO2001025469 A3 WO 2001025469A3 FR 0002753 W FR0002753 W FR 0002753W WO 0125469 A3 WO0125469 A3 WO 0125469A3
Authority
WO
WIPO (PCT)
Prior art keywords
modified
steroids
yeast fermentation
hydroxylated
yeasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2000/002753
Other languages
English (en)
Other versions
WO2001025469A2 (fr
Inventor
Gilles Cauet
Eric Degryse
Pedro Vico
Richard Lathe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to JP2001528620A priority Critical patent/JP2004500340A/ja
Priority to EP00966279A priority patent/EP1218516A2/fr
Priority to CA002386419A priority patent/CA2386419A1/fr
Priority to US10/089,803 priority patent/US7033779B1/en
Priority to AU76726/00A priority patent/AU780186B2/en
Publication of WO2001025469A2 publication Critical patent/WO2001025469A2/fr
Publication of WO2001025469A3 publication Critical patent/WO2001025469A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La présente invention concerne un procédé de production de stéroïde hydroxylé et/ou acétylé comprenant les étapes selon lesquelles: on cultive des levures sur un milieu comprenant au moins un précurseur de tels stéroïdes hydroxylés et/ou acétylés, puis on isole les stéroïdes hydroxylés et/ou acétylés du milieu après bioconversion, ledit procédé étant caractérisé en ce que lesdites levures sont des levures transformées de façon à exprimer le produit du gène Cyp7b. L'invention concerne aussi les souches de levures modifiées.
PCT/FR2000/002753 1999-10-05 2000-10-04 Procede de preparation de steroides modifies par fermentation de levures Ceased WO2001025469A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001528620A JP2004500340A (ja) 1999-10-05 2000-10-04 酵母発酵による修飾ステロイド類の製造方法
EP00966279A EP1218516A2 (fr) 1999-10-05 2000-10-04 Procede de preparation de steroides modifies par fermentation de levures
CA002386419A CA2386419A1 (fr) 1999-10-05 2000-10-04 Procede de preparation de steroides modifies par fermentation de levures
US10/089,803 US7033779B1 (en) 1999-10-05 2000-10-04 Method for preparing steroids modified by yeast fermentation
AU76726/00A AU780186B2 (en) 1999-10-05 2000-10-04 Method for preparing steroids modified by yeast fermentation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9912410A FR2799206A1 (fr) 1999-10-05 1999-10-05 Procede de production de steroides modifies par fermentation de levures
FR99/12410 1999-10-05

Publications (2)

Publication Number Publication Date
WO2001025469A2 WO2001025469A2 (fr) 2001-04-12
WO2001025469A3 true WO2001025469A3 (fr) 2002-02-28

Family

ID=9550591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/002753 Ceased WO2001025469A2 (fr) 1999-10-05 2000-10-04 Procede de preparation de steroides modifies par fermentation de levures

Country Status (7)

Country Link
US (1) US7033779B1 (fr)
EP (1) EP1218516A2 (fr)
JP (1) JP2004500340A (fr)
AU (1) AU780186B2 (fr)
CA (1) CA2386419A1 (fr)
FR (1) FR2799206A1 (fr)
WO (1) WO2001025469A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812884B1 (fr) 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012810A1 (fr) * 1994-10-19 1996-05-02 British Technology Group Proteines associees a l'hippocampe, leur codage par sequences adn et utilisation de ces proteines
WO1997037664A2 (fr) * 1996-04-09 1997-10-16 British Technology Group Ltd. Utilisation de steroides a substitution 7 alpha pour traiter les troubles neuropsychiatriques, immunitaires ou endocriniens
WO1999040203A1 (fr) * 1998-02-05 1999-08-12 Hoechst Marion Roussel Souches de levure ayant le gene atf2 interrompu et leurs applications

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012810A1 (fr) * 1994-10-19 1996-05-02 British Technology Group Proteines associees a l'hippocampe, leur codage par sequences adn et utilisation de ces proteines
WO1997037664A2 (fr) * 1996-04-09 1997-10-16 British Technology Group Ltd. Utilisation de steroides a substitution 7 alpha pour traiter les troubles neuropsychiatriques, immunitaires ou endocriniens
WO1999040203A1 (fr) * 1998-02-05 1999-08-12 Hoechst Marion Roussel Souches de levure ayant le gene atf2 interrompu et leurs applications

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ATHENSTAEDT K ET AL.: "1-Acyldihydroxyacetone-phosphate reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the open reading frame YIL124w is a major component of lipid particles", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 1, 7 January 2000 (2000-01-07), pages 235 - 240, XP002144501 *
IWASAKI M ET AL.: "Site-directed mutagenesis of mouse steroid 7-alpha-hydroxylase (cytochrome P-450-7alpha): Role of residue-209 in determining steroid-cytochrome P-450 interaction.", BIOCHEMICAL JOURNAL, vol. 291, no. 2, 1993, pages 569 - 573, XP000990764 *
KOSHCHEYENKO K A ET AL.: "Immobilization of living microbial cells and their application for steroid transformations.", ENZYME AND MICROBIAL TECHNOLOGY, vol. 5, no. 1, 1983, pages 14 - 21, XP000990744 *
NAGATA K ET AL.: "Rat testosterone 7alpha-hydroxylase. Isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 262, no. 6, 25 February 1987 (1987-02-25), pages 2787 - 2793, XP002163977 *
ROSE K A ET AL.: "Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7.alpha.-hydroxy dehydroepiandrosterone and 7.alpha.-hydroxy pregnenolone", PROC. NAT'L. ACAD. SCI. USA, vol. 94, no. 10, 13 May 1997 (1997-05-13), pages 4925 - 4930, XP002163976 *
See also references of EP1218516A2 *
WARD O P ET AL.: "Reductive biotransformations of organic compounds by cells or enzymes of yeast;", ENZYME AND MICROBIAL TECHNOLOGY, vol. 12, no. 7, 1990, pages 482 - 493, XP000990784 *

Also Published As

Publication number Publication date
JP2004500340A (ja) 2004-01-08
AU7672600A (en) 2001-05-10
EP1218516A2 (fr) 2002-07-03
US7033779B1 (en) 2006-04-25
CA2386419A1 (fr) 2001-04-12
AU780186B2 (en) 2005-03-03
FR2799206A1 (fr) 2001-04-06
WO2001025469A2 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
Plata et al. Formation of ethyl acetate and isoamyl acetate by various species of wine yeasts
Mahato et al. Steroid transformations by microorganisms—II
WO2002066667A8 (fr) Glucosamine et procede de fabrication de glucosamine a partir de biomasse microbienne
GB2089836A (en) Process for producing alcohol by fermentation without cooking
HK1045174A1 (zh) 合成有机产物的方法和材料
EP2386634A1 (fr) Protéine enzymatique de clivage de chaîne latérale de stérol et utilisation de celle-ci
EP3231870B1 (fr) Mutant depourvu de gène d'hydroxyacyl-coenzyme a déshydrogénase et son utilisation
TW200806798A (en) Process for the enantioselective reduction and oxidation, respectively, of steroids
Peart et al. The facile bioconversion of testosterone by alginate-immobilised filamentous fungi
Sripalakit et al. Biotransformation of various natural sterols to androstenones by Mycobacterium sp. and some steroid-converting microbial strains
EP1067197A3 (fr) Production de chitine et de chitosane
HRP20120806T1 (hr) Sojevi kvasca koji proizvode kolesterol i njihova upotreba
Faramarzi et al. Formation of hydroxysteroid derivatives from androst-4-en-3, 17-dione by the filamentous fungus Mucor racemosus
WO2010039812A3 (fr) Amélioration d'hydrolyse enzymatique de matériau prétraité contenant de la lignocellulose avec de la drèche sèche de distillerie
DE102006010994A1 (de) Verfahren zur enzymatischen Herstellung von chiralen Alkoholen
US4397946A (en) Process for preparing androstane steroids
WO2001025469A3 (fr) Procede de preparation de steroides modifies par fermentation de levures
IE55533B1 (en) Steroid bioconversion
WO2005118827A3 (fr) Procede de fermentation
Faramarzi et al. Microbial transformation of hydrocortisone by Acremonium strictum PTCC 5282
CN104694609A (zh) 一种植物甾醇转化为雄烯二酮转化效率的提高方法
Ambrus et al. Microbial transformation of β-sitosterol and stigmasterol into 26-oxygenated derivatives
EP0927755A3 (fr) Haloacetoacetate-reductase,procédé de préparation et procédé de préparation d'alcohols avec cette enzyme
Lu et al. Process development of transforming phytosterols to steroidal pharmaceutical intermediates by Mycolicibacterium neoaurum with L-carnitine
Perlman et al. Effect of antibiotics on oxidation of progesterone by two streptomycetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000966279

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2386419

Country of ref document: CA

Ref document number: 76726/00

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 528620

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000966279

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10089803

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 76726/00

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2000966279

Country of ref document: EP